Innovation: Endourology and Stone Disease

Innovation

Faculty within the Division of Endourology and Stone Disease engages in multidisciplinary research and individual projects, including:

  • New surgical devices and technologies
  • Biomedical engineering
  • Outcomes and health services research
  • Quality improvement research
  • Clinical trials, both investigator-initiated and industry-sponsored
  • Bioinformatics

Locally we partner with:

On a national level, Drs. Miller and Hsi are members of EDGE (Endourology Disease Group for Excellence), a multi-center research effort to advance medicine for and prevention of kidney stones, including studies for:

  • Preoperative antibiotic duration before percutaneous nephrolithotomy
  • Antibiotic prophylaxis after percutaneous nephrolithotomy
  • Holmium laser lithotripsy outcomes with MOSES technology

Other research areas of focus include:

Reducing opioids and enhanced recovery after surgery (ERAS) pathways

Opiods and enhanced recovery after surgery (ERAS) pathways​

The latest kidney stone treatments

The latest kidney stone treatments​

Holmium Laser Enucleation (HoLEP) for BPH

HoLEP​

Transdisciplinary Collaboration with Biomedical Engineering

VISE​

Big Data, informatics, and Electronic Health Records

Big Data, informatics, and Electronic Health Records​